Who Paid My Doc
ApexiCon E
Drug Treatment of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses
NDC 62559-365-30
General payments
$3,220
Research payments
$0
Through program year 2024, $3,220 in general payments and $0 in research payments were reported against ApexiCon E (Treatment of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $66 | 4 |
| 2023 | General | $2,491 | 99 |
| 2022 | General | $664 | 37 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
140 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.